Literature DB >> 22381508

Dismounted complex blast injuries: patterns of injuries and resource utilization associated with the multiple extremity amputee.

Mark Fleming1, Scott Waterman, James Dunne, Jean-Claude D'Alleyrand, Romney C Andersen.   

Abstract

The objective of this report is to analyze the resource utilization and injury patterns of complex dismounted blast injuries. A retrospective review of U.S. service members injured in combat between 2007 and 2010 was conducted. Data analyzed included age, injury mechanism, amputated limbs, number and type of associated injuries, blood products utilized, intensive care unit length of stay (ILOS), hospital length of stay (HLOS) and the Injury Severity Score (ISS). Patients were stratified based on the number of amputations. Sixty-three patients comprised the multiple extremity amputation (MEA) group. Ninety-eight percent sustained injuries from an improvised explosive device (IED) and 96% were dismounted. The ISS, number of surgical encounters, blood products utilized and ILOS were all clinically significantly different than controls. Care of multiple extremity amputees involves the utilization of significant resources. This knowledge may better help surgeons and administrators allocate assets at hospitals, both military and civilian, who care for this complex and challenging patient population.

Entities:  

Mesh:

Year:  2012        PMID: 22381508

Source DB:  PubMed          Journal:  J Surg Orthop Adv        ISSN: 1548-825X


  11 in total

1.  [Civilian blast injuries: an underestimated problem? : Results of a retrospective analysis of the TraumaRegister DGU®].

Authors:  M Kulla; J Maier; D Bieler; R Lefering; S Hentsch; L Lampl; M Helm
Journal:  Unfallchirurg       Date:  2016-10       Impact factor: 1.000

2.  Soft tissue and wound management of blast injuries.

Authors:  Andrew J Sheean; Scott M Tintle; Peter C Rhee
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

3.  Multiple blast extremity injuries: is definitive treatment achievable in a field hospital for local casualties?

Authors:  Laurent Mathieu; Erwan Saint-Macary; Martin Frank; Antoine Bertani; Frédéric Rongiéras; Paul Balandraud; Sylvain Rigal
Journal:  Int Orthop       Date:  2014-09-27       Impact factor: 3.075

4.  Impact of traumatic upper-extremity amputation on the outcome of injury caused by an antipersonnel improvised explosive device

Authors:  Shane A. Smith; Mark P. DaCambra; Vivian C. McAlister
Journal:  Can J Surg       Date:  2018-12-01       Impact factor: 2.089

5.  Combat-Related Invasive Fungal Wound Infections.

Authors:  David R Tribble; Carlos J Rodriguez
Journal:  Curr Fungal Infect Rep       Date:  2014-12-01

6.  Combat-Related Invasive Fungal Wound Infections.

Authors:  Ret Carlos J Rodriguez; Anuradha Ganesan; Faraz Shaikh; M Leigh Carson; William Bradley; Tyler E Warkentien; David R Tribble
Journal:  Mil Med       Date:  2022-05-04       Impact factor: 1.563

7.  Bilateral transfemoral/transtibial amputations due to battle injuries: a comparison of Vietnam veterans with Iraq and Afghanistan servicemembers.

Authors:  Paul J Dougherty; Lynne V McFarland; Douglas G Smith; Gayle E Reiber
Journal:  Clin Orthop Relat Res       Date:  2014-10       Impact factor: 4.176

Review 8.  Special Considerations for Multiple Limb Amputation.

Authors:  Paul F Pasquina; Matthew Miller; A J Carvalho; Michael Corcoran; James Vandersea; Elizabeth Johnson; Yin-Ting Chen
Journal:  Curr Phys Med Rehabil Rep       Date:  2014

9.  Impact of prehospital medical evacuation (MEDEVAC) transport time on combat mortality in patients with non-compressible torso injury and traumatic amputations: a retrospective study.

Authors:  Joseph K Maddry; Crystal A Perez; Alejandra G Mora; Jill D Lear; Shelia C Savell; Vikhyat S Bebarta
Journal:  Mil Med Res       Date:  2018-06-30

10.  Meeting the Challenge of a More Person-centered Future for US Healthcare.

Authors:  Bonnie R Sakallaris; William L Miller; Robert Saper; Mary Jo Kreitzer; Wayne Jonas
Journal:  Glob Adv Health Med       Date:  2016-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.